Daito Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4577.T

Daito Pharmaceutical Co.,Ltd. Price to Book Ratio (P/B) on January 14, 2025: 0.60

Daito Pharmaceutical Co.,Ltd. Price to Book Ratio (P/B) is 0.60 on January 14, 2025, a 3.66% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Daito Pharmaceutical Co.,Ltd. 52-week high Price to Book Ratio (P/B) is 0.80 on August 23, 2024, which is 34.09% above the current Price to Book Ratio (P/B).
Daito Pharmaceutical Co.,Ltd. 52-week low Price to Book Ratio (P/B) is 0.55 on January 17, 2024, which is -7.93% below the current Price to Book Ratio (P/B).
Daito Pharmaceutical Co.,Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 0.67.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Tokyo Stock Exchange: 4577.T

Daito Pharmaceutical Co.,Ltd.

CEO	Hiroshi Matsumori
IPO Date	March 24, 2010
Location	Japan
Headquarters	326, Yokamachi
Employees	1,070
Sector	Health Care
Industries Pharmaceuticals Consumer Packaged Goods

Description

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Key trends

Past 5 years